According to Fortune Business Insights, the enzymes market share was valued at USD 9,008.7 million in 2019 and is expected to grow from USD 8,919.8 million in 2020 to USD 13,815.2 million by 2027, exhibiting a CAGR of 6.4% during the forecast period (2020–2027). North America dominated the market, accounting for a 39.78% share in 2019.